Alpha 2.0
Login Register
» Articles » PMID: 22369370

Phosphorylated α-synuclein As a Potential Biomarker for Parkinson's Disease and Related Disorders

Overview
Journal Expert Rev Mol Diagn
Specialty Molecular Biology
Date 2012 Feb 29
PMID 22369370
Citations 7
Authors
Penelope Foulds
David M A Mann
David Allsop
Affiliations
Soon will be listed here.
Citing Articles

Targeted Proteomic Biomarker Profiling Using NULISA in a cohort enriched with risk for Alzheimer's Disease and Related Dementias.

Rea Reyes R, Wilson R, Langhough R, Studer R, Jonaitis E, Oomens J medRxiv. 2024; .

PMID: 39649596 PMC: 11623751. DOI: 10.1101/2024.11.28.24318162.

Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?.

Brembati V, Faustini G, Longhena F, Bellucci A Front Mol Neurosci. 2023; 16:1197853.

PMID: 37305556 PMC: 10248004. DOI: 10.3389/fnmol.2023.1197853.

Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease.

Raghunathan R, Turajane K, Wong L Int J Mol Sci. 2022; 23(16).

PMID: 36012563 PMC: 9409485. DOI: 10.3390/ijms23169299.

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences.

Koziorowski D, Figura M, Milanowski L, Szlufik S, Alster P, Madetko N Cells. 2021; 10(3).

PMID: 33809527 PMC: 7999195. DOI: 10.3390/cells10030656.

Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.

Singer W, Schmeichel A, Shahnawaz M, Schmelzer J, Boeve B, Sletten D Ann Neurol. 2020; 88(3):503-512.

PMID: 32557811 PMC: 7719613. DOI: 10.1002/ana.25824.